TSLA
Tesla, Inc.
TSLA has the edge over ZUMZ overall, supported by stronger valuation.
ZUMZ
Zumiez Inc.
ZUMZ has lower modeled downside risk, despite its lower overall score.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
ZUMZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ZUMZ's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
ZUMZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $5.19 | -63% |
| Fair | 14x | $8.64 | -39% |
| Current | 22x | $14.09 | — |
| Expensive | 25x | $16.27 | +15% |
| Forward | 34x | $14.09 | — |
Historical ranges are pointers, not guarantees.
ZUMZ has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
TSLA has the edge over ZUMZ on the outlook, with more favorable valuation and revenue expectations.
ZUMZ Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect ZUMZ's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
ZUMZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.42 | -35% |
| Q3 2026 | $0.64 | +$0.68 |
| Q2 2026 | $0.75 | +$0.77 |
| Q1 2026 | $0.78 | +$0.87 |
| Q4 2025 | $0.45 | +$3.02 |
| Q3 2025 | -$0.04 | +$2.71 |
| Q2 2025 | -$0.02 | +$3.13 |
| Q1 2025 | -$0.09 | +$3.16 |
| Q4 2024 | -$2.57 | -$1.63 |
ZUMZ has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA has the edge over ZUMZ on profitability, with a higher operating margin.
ZUMZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $209M | -2.5% |
| Q2 2026 | $193.3M | +4.9% |
| Q1 2026 | $291.3M | +4.4% |
| Q4 2025 | $239.1M | +7.5% |
| Q3 2025 | $214.3M | +1.9% |
| Q2 2025 | $184.3M | +3.9% |
| Q1 2025 | $279.2M | -0.9% |
| Q4 2024 | $222.5M | +2.8% |
ZUMZ has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | -0.7 points |
| Q2 2026 | -7.9% | +2.9 points |
| Q1 2026 | 8.6% | +1.4 points |
| Q4 2025 | 4.9% | +3.9 points |
| Q3 2025 | 0.1% | +0.2 points |
| Q2 2025 | -11% | +0.6 points |
| Q1 2025 | 7.2% | +19 points |
| Q4 2024 | 1.1% | +1.1 points |
ZUMZ's operating margin was −0.6% last quarter, down 0.7 points from the same quarter a year ago.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
ZUMZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.4M | -125% |
| Q2 2026 | -$29.8M | -$5.5M |
| Q1 2026 | $54.1M | +8.9% |
| Q4 2025 | $3.1M | +$25.4M |
| Q3 2025 | $9.5M | +$10.1M |
| Q2 2025 | -$24.3M | -$3.2M |
| Q1 2025 | $49.7M | +48% |
| Q4 2024 | -$22.3M | -$19.3M |
ZUMZ has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
ZUMZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.1% | -497K shares |
| 1 year | -5.9% | -990K shares |
| 3 years | -19% | -3.6M shares |
| 5 years | -39% | -9.9M shares |
| Available history | -39% | -9.9M shares |
ZUMZ has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $23M |
| Q2 2026 | $6M |
| Q1 2026 | — |
| Q4 2025 | $5.6M |
| Q3 2025 | $7.5M |
| Q2 2025 | $25.2M |
| Q1 2025 | — |
| Q4 2024 | $5.6M |
ZUMZ spent $35M buying back its own shares over the past year, down 9.8% from the year before.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has more cash than debt.
ZUMZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -3.4x | Net Cash |
| Q4 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -4.7x | Net Cash |
| Q4 2023 | -9.4x | Net Cash |
| Q3 2023 | -3.7x | Net Cash |
ZUMZ has the edge over TSLA on leverage, with a lower net debt burden relative to earnings.
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
ZUMZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.8 | Neutral |
| Stochastic | 18.2 | Oversold |
ZUMZ's weekly RSI is 37 (neutral) and its Stochastic is 18 (oversold).
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
ZUMZ PE vs Consumer Cyclical Sector
| Metric | ZUMZ | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 22% above |
| PE % | 76 | 47 | 29 pts above |
ZUMZ has the edge over TSLA on valuation relative to its sector.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over ZUMZ on trend strength, trading above more of its moving averages.
ZUMZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.1 | 0.2% above |
| 20 week MA | $16.3 | 14% below |
| 50 week MA | $20.9 | 33% below |
| 100 week MA | $18.6 | 24% below |
| 200 week MA | $19.0 | 26% below |
ZUMZ has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 26% below its 200-week average.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over ZUMZ on returns for 2026, with the stronger performance.
ZUMZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.7 | $36.0 | +10% |
| 2021 | $36.0 | $45.9 | +27% |
| 2022 | $45.9 | $21.0 | -54% |
| 2023 | $21.0 | $20.3 | -3.2% |
| 2024 | $20.3 | $19.5 | -4.3% |
| 2025 | $19.5 | $27.2 | +40% |
| 2026 YTD | $27.2 | $14.1 | -48% |
ZUMZ has finished lower in three of the last six years. It's down 48% so far in 2026.